Triochem Products
TRIOCHEMPRODUCTSLTD NSE
Triochem Products
HealthcareNSE: TRIOCHEMPRODUCTSLTD BSE: 512101 Pharmaceuticals
Key Fundamentals
MicrocapPharmaceuticalsHealthcareMarket Cap
₹0.00 Cr
Volatility
Low Risk
P/E Ratio
0
EBITDA
₹-0.50 Cr
Return on Equity
38.6%
Debt to Equity
0
Book Value
₹478.88
EPS
₹0
52W High
₹0
52W Low
₹0
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
2- Company is almost debt free.
- Stock is trading at 0.02 times its book value
Weaknesses
2- Company has low interest coverage ratio.
- Company has a low return on equity of -15.6% over last 3 years.
Growth Rate
Revenue Growth
-18.18% lower than
3Y
Net Income Growth
—
Cash Flow Change
—
ROE
—
ROCE
—
EBITDA Margin (Avg.)
274% lower than
3Y
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.26 | 0.29 | 0.24 | 0.33 | 0.31 | 0.3 | 0.59 | 0.33 | 0.36 | 0.43 | 0.38 | 0.22 | 0.05 |
| Operating Profit | -0.26 | -0.29 | -0.24 | -0.33 | -0.31 | -0.3 | -0.59 | -0.33 | -0.36 | -0.43 | -0.38 | -0.22 | -0.05 |
| Other Income | 0.14 | -1.11 | 0.04 | 0.8 | 0.23 | 0.27 | 0.46 | 0.32 | 0.22 | 0.3 | 0.22 | 11.29 | 0.17 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.08 | 0 |
| Depreciation | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.04 | 0.02 | 0.02 | 0.02 | 0.01 | 0 | 0 |
| PBT | -0.14 | -1.42 | -0.22 | 0.45 | -0.1 | -0.05 | -0.17 | -0.03 | -0.16 | -0.15 | -0.17 | 10.99 | 0.12 |
| Tax % | -21.43% | -27.46% | -4.55% | 28.89% | -20% | -20% | -147.06% | 1400% | -75% | 33.33% | -23.53% | 24.2% | 25% |
| Net Profit | -0.11 | -1.03 | -0.2 | 0.32 | -0.08 | -0.04 | 0.09 | -0.45 | -0.03 | -0.19 | -0.13 | 8.33 | 0.09 |
| EPS in Rs | -4.49 | -42.04 | -8.16 | 13.06 | -3.27 | -1.63 | 3.67 | -18.37 | -1.22 | -7.76 | -5.31 | 340 | 3.67 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 30.68 | 23.11 | 18.06 | 34.99 | 12.35 | 20.03 | 13.94 | 8.82 | 0 | 0 | -0.01 | -0.03 | 0 |
| Expenses | 29.44 | 22.11 | 17.07 | 31.18 | 10.71 | 15.48 | 14.3 | 7.47 | 1.33 | 1.05 | 1.21 | 1.34 | 1.08 |
| Operating Profit | 1.24 | 1 | 0.99 | 3.81 | 1.64 | 4.55 | -0.36 | 1.35 | -1.33 | -1.05 | -1.22 | -1.37 | -1.08 |
| OPM % | 4.04% | 4.33% | 5.48% | 10.89% | 13.28% | 22.72% | -2.58% | 15.31% | — | — | — | — | — |
| Other Income | 0.08 | -0.01 | 0.16 | 0.41 | 0.06 | 0.47 | 0.13 | 0.55 | 0.27 | -0.19 | 1.05 | 12.03 | 11.98 |
| Interest | 0.45 | 0.2 | 0.07 | 0.4 | 0.46 | 0.3 | 0.21 | 0.02 | 0 | 0 | 0 | 0.1 | 0.08 |
| Depreciation | 0.32 | 0.27 | 0.28 | 0.25 | 0.21 | 0.17 | 0.14 | 0.12 | 0.11 | 0.09 | 0.08 | 0.05 | 0.03 |
| PBT | 0.55 | 0.52 | 0.8 | 3.57 | 1.03 | 4.55 | -0.58 | 1.76 | -1.17 | -1.33 | -0.25 | 10.51 | 10.79 |
| Tax % | 23.64% | 32.69% | 28.75% | 28.57% | 29.13% | 25.27% | -24.14% | 25% | -24.79% | -24.06% | 60% | 24.17% | — |
| Net Profit | 0.42 | 0.34 | 0.58 | 2.56 | 0.74 | 3.4 | -0.45 | 1.32 | -0.89 | -1.01 | -0.4 | 7.97 | 8.1 |
| EPS in Rs | 17.14 | 13.88 | 23.67 | 104 | 30.2 | 139 | -18.37 | 53.88 | -36.33 | -41.22 | -16.33 | 325 | 331 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 |
| Reserves | 4.31 | 4.65 | 5.24 | 7.79 | 8.53 | 11.93 | 11.47 | 12.8 | 11.35 | 14.38 | 13.42 | 20.4 |
| Borrowings | 3.5 | 0 | 2.86 | 2.28 | 5.79 | 2.5 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0.42 | 2.12 | 1.93 | 1.47 | 0.58 | 1.94 | 0.38 | 0.28 | 0.24 | 0.25 | 0.23 | 0.23 |
| Total Liabilities | 8.48 | 7.02 | 10.28 | 11.79 | 15.15 | 16.62 | 12.1 | 13.33 | 11.84 | 14.88 | 13.9 | 20.88 |
| Fixed Assets | 1.72 | 1.85 | 1.64 | 1.42 | 1.22 | 1.06 | 0.94 | 0.87 | 0.77 | 0.68 | 0.6 | 0 |
| CWIP | 0.37 | 0.04 | 0 | 0 | 0 | 0.03 | 0.03 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0.12 | 3.68 | 0 | 0 | 0 | 0 | 0 | 0 | 9.42 | 11.07 | 10.63 | 7.89 |
| Other Assets | 6.27 | 1.45 | 8.64 | 10.37 | 13.93 | 15.53 | 11.13 | 12.46 | 1.65 | 3.13 | 2.67 | 12.99 |
| Total Assets | 8.48 | 7.02 | 10.28 | 11.79 | 15.15 | 16.62 | 12.1 | 13.33 | 11.84 | 14.88 | 13.9 | 20.88 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 2.34 | 6.79 | -6.48 | 1.45 | -3.75 | 3.82 | 10.25 | 3.47 | -1.03 | -3.76 | 0.2 | -2.87 |
| Investing | -0.1 | -3.7 | 3.71 | -0.01 | 0.02 | -0.03 | 0 | 0.16 | -9.82 | 3.34 | 0.17 | 13.7 |
| Financing | -1.69 | -3.68 | 2.8 | -0.92 | 3.06 | -3.49 | -2.61 | -0.02 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0.56 | -0.59 | 0.03 | 0.52 | -0.67 | 0.3 | 7.64 | 3.61 | -10.85 | -0.42 | 0.37 | 10.82 |
| Free Cash Flow | 2.24 | 6.68 | -6.51 | 1.42 | -3.76 | 3.79 | 10.23 | 3.44 | -1.03 | -3.76 | 0.2 | 8.85 |
| CFO/OP | 241 | 682 | -635 | 56 | -176 | 106 | -2,939 | 287 | 105 | 351 | -17 | 64 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 2.02 | 0 | 49.52 | 0 | 98.42 | 226 | 36.4 | 0 | — | — | 0 | 0 |
| Inventory Days | 55.65 | 5.85 | 52.93 | 104 | 414 | 41.57 | 24.6 | 2.9 | — | — | 0 | 0 |
| Days Payable | 1.45 | 31.02 | 36.57 | 9.13 | 14.72 | 19.85 | 9.26 | 9.85 | — | — | — | — |
| Cash Conversion Cycle | 56.22 | -25.17 | 65.88 | 95.24 | 498 | 248 | 51.74 | -6.95 | — | — | 0 | 0 |
| Working Capital Days | 16.06 | -19.43 | 63.06 | 56.23 | 217 | 191 | 63.1 | 0.83 | — | — | 50,735 | 14,965 |
| ROCE % | 11.78% | 11.57% | 12.83% | 42.53% | 11.97% | 33.16% | -2.8% | 14.45% | -10.14% | -2.67% | -3.32% | -4.37% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Triochem Products insights
63 extracted metrics + investor summaries across FY10–FY26.
Documents
2
Disclosures By Listed Entities Of Defaults On Payment Of Interest/ Repayment Of Principal Amount For Loans
Including Revolving Facilities Like Cash Credit From Banks / Financial Institutions
16 Apr - Quarterly default disclosure for 31 March 2026 shows nil debt and nil defaults. 16 Apr - Quarterly default disclosure for 31 March 2026 shows nil debt and nil defaults.
3
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
16 Apr - Company confirms it is not a Large Corporate; initial disclosure for FY2026 not required. 16 Apr - Company confirms it is not a Large Corporate; initial disclosure for FY2026 not required.
4
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
16 Apr - Triochem Products says it is not a large corporate; no initial disclosure required for year ended March 31, 2026. 16 Apr - Triochem Products says it is not a large corporate; no initial disclosure required for year ended March 31, 2026.
5
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
16 Apr - Submitted Regulation 74(5) certificate for quarter ended 31 March 2026. 16 Apr - Submitted Regulation 74(5) certificate for quarter ended 31 March 2026.
Frequently Asked Questions about Triochem Products
What does Triochem Products Ltd do?
Triochem Products engaged primarily in the business of manufacturer and exporter of pharlnaceuticals products, Apls and chemicals.
Where is Triochem Products Ltd (512101) listed?
Triochem Products Ltd trades as TRIOCHEMPRODUCTSLTD on the NSE and under code 512101 on the BSE.
Which sector does Triochem Products Ltd belong to?
Triochem Products Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Triochem Products Ltd?
Triochem Products Ltd has a market capitalisation of ₹0, which places it in the Small Cap band.
What is the PE ratio of Triochem Products Ltd?
Triochem Products Ltd trades at a PE ratio of 0.00, on earnings per share of ₹0, against a book value of ₹478.88 per share.
What is the 52-week high and low of Triochem Products Ltd?
Over the last 52 weeks Triochem Products Ltd has traded between ₹0 and ₹0.
What is the Return on Equity (ROE) of Triochem Products Ltd?
Triochem Products Ltd reported a return on equity of 38.60%. Its debt-to-equity ratio is 0.00.
Company Information
Triochem Products engaged primarily in the business of manufacturer and exporter of pharlnaceuticals products, Apls and chemicals.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/512101.md for Triochem Products Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.